GILBERTSVILLE, Pa.—Rockland
Immunochemicals Inc., a
biotechnology company focusing on antibodies and antibody based tools for basic
research, assay development and preclinical
studies, announced in mid-December
its acquisition of the TrueBlot IP/Western blot product line from eBioscience
Inc., an Affymetrix company.

"The acquisition of the TrueBlot product line expands
Rockland's Western blot workflow product offerings and will allow our customers
to perform protein research in a more efficient and effective manner,
ultimately saving time and precious research dollars," said Rockland President
and CEO Jim Fendrick in a press release announcing the acquisition. "The
TrueBlot brand has an excellent reputation and is widely considered
best-in-class among Western blotting reagents."

Rockland will market the TrueBlot IP/Western blot
product
line on its e-commerce website and through its existing global distribution
network.